Skip to main content
Alphanox Co.,Ltd. logo

Alphanox Co.,Ltd. — Investor Relations & Filings

Ticker · 043100 ISIN · KR7043100007 KO Manufacturing
Open in API
Filings indexed 364 across all filing types
Latest filing 2026-04-07 Regulatory Filings
Country KR South Korea
Listing KO 043100

About Alphanox Co.,Ltd.

https://alphanox.co.kr/en/

Alphanox Co.,Ltd., formerly known as Solco Biomedical, is a global medical and healthcare group established in 1974. The company specializes in the development, manufacturing, and sale of advanced medical devices and health-promoting products. Its primary product lines include surgical instruments, orthopedic implants with a strong focus on spinal applications, and in-vitro diagnostic devices. In addition to its core medical offerings, Alphanox also produces healthcare products such as functional water and other health-promoting devices. The company is committed to improving quality of life through extensive research and development grounded in medical engineering and clinical results.

Recent filings

Filing Released Lang Actions
주권매매거래정지 (풍문 또는 보도 관련)
Regulatory Filings Classification · 85% confidence The document is a short regulatory announcement in Korean concerning the suspension of trading in a company’s ordinary shares (‘‘주권매매거래정지’’) under KOSDAQ market rules. It provides reasons, dates, and regulatory citations but contains no financial statements or management commentary. It is not an earnings release, financial report, or capital change notice; instead, it is a regulatory market notice. Thus, it is classified as a Regulatory Filing (RNS).
2026-04-07 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 90% confidence The document is titled "정기주주총회결과" and details the results of motions approved or deferred at the Annual General Meeting (AGM), including vote outcomes on financial statements, director appointments, and auditor remuneration. This is clearly a post-AGM vote results announcement rather than the meeting notice or the underlying reports. Therefore it falls under Declaration of Voting Results & Voting Rights Announcements (Code: DVA).
2026-03-31 Korean
[기재정정]주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 85% confidence The document is a Korean "주요사항보고서(전환사채권 발행결정) 정정신고," containing detailed terms of a convertible bond issuance (interest, maturity, conversion, options, use of proceeds, etc.). This is not merely an announcement of an upcoming report but the full regulatory filing for a financing event – specifically a capital market financing through convertible bonds. According to the category definitions, this most closely matches “Capital/Financing Update (CAP).”
2026-03-25 Korean
[기재정정]주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 85% confidence The document is a detailed Korean regulatory filing (‘주요사항보고서’) notifying and correcting the terms of a convertible bond issuance by Alpha AI (including maturity, interest dates, conversion terms, put options, etc.). This is not an AGM presentation, earnings release, management change, or full annual/interim report. It is a financing update concerning a debt instrument (convertible bonds) and constitutes a capital/financing activity announcement.
2026-03-25 Korean
[기재정정]타법인주식및출자증권취득결정
Major Shareholding Notification Classification · 75% confidence The document is a Korean statutory disclosure titled “타법인주식및출자증권취득결정” detailing the board’s decision to acquire 2,500,000 shares (7.33%) of another company, including amounts, percentages, scheduled dates, method of acquisition, and reasons for a correction. It is not a fundraising or internal financial report, nor a report on its own share buyback, but rather a notification of a significant change in the company’s shareholding position in another entity crossing the 5% threshold. That matches our “Major Shareholding Notification” category (MRQ).
2026-03-25 Korean
사업보고서제출기한연장신고서 (2025.12)
Regulatory Filings Classification · 80% confidence The document is a Korean "사업보고서 제출 기한 연장 신고서" (business report submission deadline extension notice), notifying regulators (Financial Services Commission, Korea Exchange) that the company cannot file its annual business report (31st term) by the original deadline due to audit delays. It is not the actual annual report (10-K/AR), nor a vote result, management change, earnings release, or other specific category. It is a regulatory announcement that does not fit more specific categories, so it falls under the general Regulatory Filings (RNS) category.
2026-03-24 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.